Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700027544

Trial Profile

Clinical Trials Insight: 700027544

Phase of Trial: Phase II

Latest Information Update: 27 Aug 2010

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Aug 2010 Resuls presented at the 40th Annual Meeting of the International Continence Society and the 35th International UroGynecological Association (Joint Meeting).
    • 29 Sep 2009 Results have been presented at the 39th Annual Meeting of the International Continence Society.
    • 11 Oct 2007 Results reported at the ICS 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top